retatrutide trial sign up australia Phase 3: TRIUMPH Program Results 2026 Reta 10 and Reta 20

The Impact of Novel Medications for Obesity on Weight Stigma and Societal Attitudes: A Narrative Review

Eli Lilly's triple agonist demonstrates an unprecedented level of efficacy, coupled with a tolerability profile that suggests it could be a game-changer for patients and clinicians

Like Wegovy, Zepbound is FDA-approved for weight management in adults with obesity (BMI of 30 or higher) or overweight (BMI of 27 or higher) and related health issues like high blood pressure or diabetes

Vilsbll T, Krarup T, Sonne J, Madsbad S, Vlund A, Juul AG, et al

This article examines the evidence, safety considerations, and alternative treatment options for managing type 2 diabetes effectively

WL, weight loss